Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
about
Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug usersPrimary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national surveyIs ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseasesHelicobacter pylori and nonmalignant diseases.Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled triaManagement of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs. Joint opinion statement of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy.Efficacy and safety of rabeprazole in non-steroidal anti-inflammatory drug-induced ulcer in Japan.Helicobacter pylori-negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence: Multicenter follow-up study of peptic ulcers in Japan.Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial.Healing and Antisecretory Effects of Aqueous Extract of Eremomastax speciosa (Acanthaceae) on Unhealed Gastric Ulcers.
P2860
Q28182449-D214CEA4-FE49-4D5B-9295-25D29917E343Q28195079-BE5CFE5E-1F2E-49CC-9E0B-A6EF7806A53AQ28201393-93D52412-D7C5-4FB1-98D5-F14753A97FBDQ28219634-65F1FEA8-AF70-4CAA-B346-ABD0936195D4Q35583575-7B3A3F27-AE5B-4D0A-B49F-457A05A9BF50Q35989849-01F7A1CC-22EA-4C1E-A457-525163DA3ED5Q37173212-24E080F2-7F6D-4A00-93D6-44FC6AAEC77FQ37402476-DCF7B411-F0A5-4235-B641-81ECF2FDB51DQ40795760-8CB37F29-97A6-4968-836A-2BBCEDF5C22DQ41997560-9601D986-690E-4711-A19C-13542A032080Q42751878-DC150F35-B7C7-4297-A68B-04A29A74AE6DQ43216541-6ECD37CD-531D-43FB-909A-D3138C267DBFQ44678732-CFDFF681-5217-454F-84A2-E063F074B117Q46879529-0613E13E-1399-4654-9585-3EE4717B2F6FQ47102201-12C2414E-BB8D-4B8D-9A37-AEDAAFB7FC7D
P2860
Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effect of H. pylori status on ...... th lansoprazole or ranitidine.
@en
Effect of H. pylori status on ...... th lansoprazole or ranitidine.
@nl
type
label
Effect of H. pylori status on ...... th lansoprazole or ranitidine.
@en
Effect of H. pylori status on ...... th lansoprazole or ranitidine.
@nl
prefLabel
Effect of H. pylori status on ...... th lansoprazole or ranitidine.
@en
Effect of H. pylori status on ...... th lansoprazole or ranitidine.
@nl
P2093
P2860
P1476
Effect of H. pylori status on ...... th lansoprazole or ranitidine.
@en
P2093
Bidan Huang
Cyndy Collis
Donald R Campbell
Jay L Goldstein
Marian M Haber
Nancy Lukasik
P2860
P304
P356
10.1111/J.1572-0241.2002.05774.X
P407
P50
P577
2002-09-01T00:00:00Z